120 related articles for article (PubMed ID: 38555852)
1. Relationship between serum apelin, visfatin levels, and body composition in Polycystic Ovary Syndrome patients.
Kuai D; Tang Q; Wang X; Yan Q; Tian W; Zhang H
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():24-29. PubMed ID: 38555852
[TBL] [Abstract][Full Text] [Related]
2. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
[TBL] [Abstract][Full Text] [Related]
3. Plasma visfatin and apelin levels in adolescents with polycystic ovary syndrome.
Ruan X; Li M; Min M; Ju R; Wang H; Xu Z; Luo S; Mueck AO
Gynecol Endocrinol; 2023 May; 39(1):2216807. PubMed ID: 37248950
[TBL] [Abstract][Full Text] [Related]
4. Spleen-yang-deficiency patients with polycystic ovary syndrome have higher levels of visfatin.
Fu H; Qiu Y; Xia M; Wei F; He H; Yang L
J Tradit Chin Med; 2014 Feb; 34(1):42-7. PubMed ID: 25102689
[TBL] [Abstract][Full Text] [Related]
5. Plasma visfatin level in women with polycystic ovary syndrome.
Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
[TBL] [Abstract][Full Text] [Related]
6. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
[TBL] [Abstract][Full Text] [Related]
7. Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome.
Lajunen TK; Purhonen AK; Haapea M; Ruokonen A; Puukka K; Hartikainen AL; Savolainen MJ; Morin-Papunen L; Tapanainen JS; Franks S; Järvelin MR; Herzig KH
Eur J Clin Invest; 2012 Mar; 42(3):321-8. PubMed ID: 21913913
[TBL] [Abstract][Full Text] [Related]
8. Visfatin and SREBP-1c mRNA Expressions and Serum Levels Among Egyptian Women with Polycystic Ovary Syndrome.
Abdul-Maksoud RS; Zidan HE; Saleh HS; Amer SA
Genet Test Mol Biomarkers; 2020 Jul; 24(7):409-419. PubMed ID: 32460545
[No Abstract] [Full Text] [Related]
9. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
Ezeh U; Pall M; Mathur R; Azziz R
Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
[TBL] [Abstract][Full Text] [Related]
10. Serum visfatin levels in women with polycystic ovary syndrome.
Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
[TBL] [Abstract][Full Text] [Related]
11. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin.
Sun X; Wu X; Zhou Y; Yu X; Zhang W
Med Sci Monit; 2015 Aug; 21():2547-52. PubMed ID: 26314870
[TBL] [Abstract][Full Text] [Related]
13. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J
Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018
[TBL] [Abstract][Full Text] [Related]
14. Plasma Visfatin Levels in Adolescents with Polycystic Ovary Syndrome: A Prospective Case-Control Study.
Gümüş Ü; Güzel AI; Topcu HO; Timur H; Yılmaz N; Danışman N
J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):249-53. PubMed ID: 26049941
[TBL] [Abstract][Full Text] [Related]
15. Fat-free mass index is a feasible predictor of insulin resistance in women with polycystic ovary syndrome: Evidence from a cross-sectional study.
Guo J; Lin B; Niu R; Lu W; He C; Zhang M; Huang Y; Chen X; Liu C
Endocrine; 2024 May; 84(2):420-426. PubMed ID: 37950131
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence Rate of Adult Sarcopenic Obesity and Correlation of Appendicular Skeletal Muscle Mass Index with Body Mass Index, Percent Body Fat, Waist-Hip Ratio, Basal Metabolic Rate, and Visceral Fat Area.
Luo X; Cai B; Jin W
Metab Syndr Relat Disord; 2023 Feb; 21(1):48-56. PubMed ID: 36318808
[No Abstract] [Full Text] [Related]
17. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
Gul OO; Cander S; Gul B; Açıkgoz E; Sarandol E; Ersoy C
Eur Cytokine Netw; 2015; 26(4):73-8. PubMed ID: 26967765
[TBL] [Abstract][Full Text] [Related]
20. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
